Product Details
Relenza
Zanamivir5 mg
Powder for Inhalation
5's Rotadisks Pack
DIN/PIN/NPN
02240863
Manufacturer
GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
Formulary Listing Date
2010-03-02
Unit Price
46.5300
Amount MOH Pays
46.5300
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
J05AH01
Interchangeable Products
NOLU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| Note: For the treatment or prophylaxis of institutionalized individuals during confirmed outbreaks due to influenza A or Influenza B when the predominant circulating strain is resistant to oseltamivir or for the prophylaxis of influenza A, where new cases have developed despite amantadine prophylaxis. The outbreak must be confirmed by Public Health. | ||
| 414 | 1 year | For treatment: 2 inhalations of 5mg (10mg) bid for 5 days, |
| 415 | 1 year | For prophylaxis: 2 inhalations of 5mg (10mg) once daily for 10 days. |